| 000 | 01714 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517194438.0 | ||
| 264 | 0 | _c20190513 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1875-5828 | ||
| 024 | 7 |
_a10.2174/1567205015666180110110321 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Hui | |
| 245 | 0 | 0 |
_aAmyloid-β Inhibits PDGFβ Receptor Activation and Prevents PDGF-BBInduced Neuroprotection. _h[electronic resource] |
| 260 |
_bCurrent Alzheimer research _c2018 |
||
| 300 |
_a618-627 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBecaplermin _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aHippocampus _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotection _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aPeptide Fragments _xmetabolism |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 | _aPrimary Cell Culture |
| 650 | 0 | 4 |
_aReceptor, Platelet-Derived Growth Factor beta _xmetabolism |
| 650 | 0 | 4 |
_aSerotonin _xmetabolism |
| 700 | 1 | _aSaffi, Golam T | |
| 700 | 1 | _aVasefi, Maryam S | |
| 700 | 1 | _aChoi, Youngjik | |
| 700 | 1 | _aKruk, Jeff S | |
| 700 | 1 | _aAhmed, Nawaz | |
| 700 | 1 | _aGondora, Nyasha | |
| 700 | 1 | _aMielke, John | |
| 700 | 1 | _aLeonenko, Zoya | |
| 700 | 1 | _aBeazely, Michael A | |
| 773 | 0 |
_tCurrent Alzheimer research _gvol. 15 _gno. 7 _gp. 618-627 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1567205015666180110110321 _zAvailable from publisher's website |
| 999 |
_c27978585 _d27978585 |
||